Skip to main content
Oral antiamyloid shows disease-modifying potential Phase 3 trial underway
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Oral antiamyloid shows disease-modifying potential Phase 3 trial underway
User login
Username
Password
Reset your password
Concept
Lead
score
Alzheimer Disease
1
1
Plasma
0
0.76
Biomarker
0
0.48
Amyloid-Beta
0
0.19
Brain
0
0.19
Grant
0
0.19
Mild Cognitive Impairment
0
0.15
Cognitive Impairment
0
0.14
Caregiver
0
0.1
Cognition
0
0.1
Edema
0
0.1
Impairment
0
0.1
Injury
0
0.1
Match
0
0.1
Nausea
0
0.1
Neuroimaging
0
0.1
COVID-19
0
0.09
Wound Management
0
0.09
Specialty
Lead
score
Neurology & Neurosurgery
1
1
Psychiatry
0
0.9
Edit Tags